Telomerase activity and telomere length distribution in vascular endothelial cells in a short-term culture under the presence of hydrogen peroxide

Geriatrics and Gerontology International

Volumn 13, Issue 3, 2013, Pages 774-782

  Maeda, Toyoki ^a   Guan, Jing Zhi ^b   Koyanagi, Masamichi ^a   Makino, Naoki ^a  

^a KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^b 309TH HOSPITAL OF PLA   (China)

Author keywords

Cell senescence; Hydrogen peroxide; Telomerase; Telomere; Telomeric proteins; Vascular endothelial cell

Indexed keywords

BETA ACTIN; BETA GALACTOSIDASE; HYDROGEN PEROXIDE; TELOMERASE; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2;

ARTICLE; CELL AGING; CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CHROMOSOME SIZE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE; VASCULAR ENDOTHELIUM;

CELL SENESCENCE; HYDROGEN PEROXIDE; TELOMERASE; TELOMERE; TELOMERIC PROTEINS; VASCULAR ENDOTHELIAL CELL;

BLOTTING, WESTERN; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TELOMERASE; TELOMERE;

EID: 84880011881     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2012.00936.x     Document Type: Article

References (45)

1. Blackburn EH. Structure and function of telomeres. Nature (London) 1991; 350: 569-573.
2. Zakian VA. Telomeres: beginning to understand the end. Science 1995; 270: 1601-1607.
3. Iwama H, Ohyashiki K, Ohyashiki JH etal. Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet 1998; 102: 397-402.
4. Guan JZ, Maeda T, Sugano M, Oyama J, Higuchi Y, Makino N. Change in the telomere length distribution with age in the Japanese population. Mol Cell Biochem 2007a; 304: 253-260.
5. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev 2008; 88: 557-579.
6. Okuda K, Khan MY, Skurnick J, Kimura M, Aviv H, Aviv A. Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis. Atherosclerosis 2000; 152: 391-398.
7. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2003; 23: 842-846.
8. Epel ES, Blackburn EH, Lin J etal. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA. 2004; 101: 17312-17315.
9. Valdes AM, Andrew T, Gardner JP etal. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-664.
10. Uziel O, Singer JA, Danicek V etal. Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control. Exp Gerontol 2007; 42: 971-978.
11. Panossian LA, Porter VR, Valenzuela HF etal. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 2003; 24: 77-84.
12. Guan JZ, Maeda T, Sugano M etal. An analysis of telomere length in sarcoidosis. J Gerontol A Biol Sci Med Sci 2007b; 62: 1199-1203.
13. Guan JZ, Maeda T, Sugano M etal. A percentage analysis of the telomere length in Parkinson's disease patients. J Gerontol A Biol Sci Med Sci 2008; 63: 467-473.
14. 2-induced premature senescence of human foreskin fibroblasts expressing or not telomerase. Exp Gerontol 2004; 39: 1379-1389.
15. Yudoh K, Nguyen T, Nakamura H, Hongo-Masuko K, Kato T, Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 2005; 7: R380-R391.
16. Huang XQ, Wang J, Liu JP etal. hTERT extends proliferative lifespan and prevents oxidative stress-induced apoptosis in human lens epithelial cells. Invest Ophthalmol Vis Sci 2005; 46: 2503-2513.
17. 2 involves DNA-damage-and-repair genes and telomere shortening. Int J Biochem Cell Biol 2005; 37: 1407-1420.
18. 2 is Src kinase dependent. Exp Gerontol 2010; 45: 558-562.
19. Itabe H. Oxidative modification of LDL: its pathological role in atherosclerosis. Clin Rev Allergy Immunol 2009; 37: 4-11.
20. de Lange T, Shiue L, Myers RM etal. Structure and variability of human chromosome ends. Mol Cell Biol 1990; 10: 518-527.
21. Tao Q, Lv B, Qiao B, Zheng CQ, Chen ZF. Immortalization of ameloblastoma cells via reactivation of telomerase function: phenotypic and molecular characteristics. Oral Oncol 2009; 45: e239-e244.
22. Fuiwara M, Kamma H, Wu W, Yano Y, Homma S, Satoh H. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R. Internatl J Oncol 2006; 29: 445-451.
23. Makino N, Maeda T, Oyama J-I, Higuchi Y, Mimori K. Improving insulin sensitivity via activation of PPAR-γ increases telomerase activity in the heart of OLETF rats. Am J Physiol Heart Circ Physiol 2009; 297: H2188-H2195.
24. Harrington L, Zhou W, McPhail T etal. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 1997; 11: 3109-3115.
25. Meyerson M, Counter CM, Eaton EN etal. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997; 90: 785-795.
26. Sugano M, Tsuchida K, Maeda T, Makino N. siRNA targeting SHP-1 accelerates angiogenesis in a rat model of hindlimb ischemia. Atherosclerosis 2007; 191: 33-39.
27. Nagata T, Takada Y, Ono A etal. Elucidation of the mode of interaction in the UP1-telomerase RNA-telomeric DNA ternary complex which serves to recruit telomerase to telomeric DNA and to enhance the telomerase activity. Nucleic Acids Res 2008; 36: 6816-6824.
28. 2-induced senescence without affecting telomerase enzymatic activity. Biochem Biophys Res Commun 2003; 301: 627-632.
29. Katakura Y, Yoshizaki K, Yasuda T etal. Functional impairment of telomerase in sublines derived from human lung adenocarcinoma exposed to mild oxidative stress. Biochem Biophys Res Commun 2005; 334: 450-459.
30. Sheng R, Gu ZL, Xie ML, Zhou WX, Guo CY. Epigallocatechin gallate protects H9c2 cardiomyoblasts against hydrogen dioxidesinduced apoptosis and telomere attrition. Eur J Pharmacol 2010; 641: 199-206.
31. Nitta E, Yamashita M, Hosokawa K etal. Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere independent mechanism. Blood 2011; 117: 4169-4180.
32. Indran IR, Hande MP, Pervaiz S. hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res 2011; 71: 266-276.
33. Makpol S, Abidin AZ, Sairin K, Mazlan M, Top GM, Ngah WZ. -Tocotrienol prevents oxidative stress-induced telomere shortening in human fibroblasts derived from different aged individuals. Oxidative Medicine and Cellular Longevity 2010; 3 (1): 35-43.
34. Yokoo S, Furumoto K, Hiyama E, Miwa N. Slow-down of age-dependent telomere shortening is executed in human skin keratinocytes by hormesis-like-effects of trace hydrogen peroxide or by anti-oxidative effects of pro-vitamin C in common concurrently with reduction of intracellular oxidative stress. J Cell Biochem 2004; 93: 588-597.
35. Ahmed S, Passos JF, Birket MJ etal. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci 2008; 121: 1046-1053.
36. Napier CE, Veas LA, Kan CY etal. Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells. Biochim Biophys Acta 2010; 1803: 1142-1153.
37. Chebel A, Rouault JP, Urbanowicz I etal. Transcriptional activation of hTERT, the human telomerase reverse transcriptase, by nuclear factor of activated T cells. J Biol Chem 2009; 284: 35725-35734.
38. Akiyama M, Kawano T, Mikami-Terao Y etal. Erythropoietin activates telomerase through transcriptional and posttranscriptional regulation in human erythroleukemic JAS-REN-A cells. Leuk Res 2011; 35: 416-418.
39. van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature (London) 1997; 385: 740-743.
40. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998; 92: 401-413.
41. Zhang P, Dilley C, Mattson MP. DNA damage responses in neural cells: focus on the telomere. Neuroscience 2007; 145: 1439-1448.
42. Smogorzewska A, van Steensel B, Bianchi A etal. Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 2000; 20: 1659-1668.
43. Soohoo CY, Shi R, Lee TH, Huang P, Lu KP, Zhou XZ. Telomerase inhibitor PinX1 provides a link between TRF1and telomerase to prevent telomere elongation. J Biol Chem 2011; 286: 3894-3906.
44. McKerlie MA, Lin S, Zhu XD. ATM regulates proteasome-dependent subnuclear localization of TRF1, which is important for telomere maintenance. Nucl Acids Res 2012; 40: 3975-3989.
45. Miura N, Horikawa I, Nishimoto A etal. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet 1997; 93: 56-62.